EP-37161

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameEP-37161
Drug Alias NameIndirect Factor Xa Antagonist (Endotis Pharma)EP-37161
ClassificationSmall molecules > Carbohydrate > Oligosaccharide
Mechanisms of ActionCoagulation factor X inhibitorsHeparanase inhibitors
TargetsHeparanaseCoagulation factor X
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEndotis Pharma SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndotis Pharma SA
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A